848611-30-3

Upstream product

• 64957-88-6 4,4-dimethyl-2-(2,4,5-trimethoxy-phenyl)-4,5-dihydro-oxazole 
• 5424-43-1 3-bromoveratrole 

Downstream Products

• 848610-57-1 5-[1-(2,3-dimethoxyphenyl)-1-methylethyl]-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 1098073-43-8 5-[1-(2,3-dimethoxyphenyl)cyclohexyl]-2,2-dimethyl-1,3-dioxane-4,6-dione 
• 152911-43-8 (2-amino-5-chlorophenyl)(2,3-dimethoxyphenyl)methanone 
• 951396-66-0 C₂₇H₃₈O₅Si 
• 1268868-59-2 (1S,4S,6R)-6-benzyloxy-4-[(tert-butyldimethylsilyl)oxy]-1-(2,3-dimethoxyphenyl)-2-cyclohexen-1-ol 
• 1268868-60-5 (1R,4S,6R)-6-benzyloxy-4-[(tert-butyldimethylsilyl)oxy]-1-(2,3-dimethoxyphenyl)-2-cyclohexen-1-ol 
• 1268868-53-6 (1R,4R,6S)-6-benzyloxy-4-[(tert-butyldimethylsilyl)oxy]-1-(2,3-dimethoxyphenyl)-2-cyclohexen-1-ol 
• 1268868-57-0 (1S,4R,6S)-6-benzyloxy-4-[(tert-butyldimethylsilyl)oxy]-1-(2,3-dimethoxyphenyl)-2-cyclohexen-1-ol 
• 406684-81-9 methyl N-[(3S,5R)-7-chloro-5-(2,3-dimethoxyphenyl)-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]-L-leucinate 
• 406684-80-8 methyl N-[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]-L-leucinate 
• 152911-97-2 (E)-3-[{4-Chloro-2-[(2,3-dimethoxy-phenyl)-hydroxy-methyl]-phenyl}-(2,2-dimethyl-propyl)-carbamoyl]-acrylic acid ethyl ester 
• 152911-75-6 [5-chloro-2-(2,2-dimethylpropylamino)phenyl]-(2,3-dimethoxyphenyl)methanol 
• 152911-54-1 (+/-)-2-amino-5-chloro-α-(2,3-dimethoxyphenyl)benzyl alcohol 
• 951396-64-8 (1S,4R,6S)-6-benzyloxy-4-[(tert-butyldimethylsilyl)oxy]-1-(2,3-dimethoxyphenyl)-2-cyclohexene-1-acetic acid ethyl ester 

Relevant academic research and scientific papers

Piperazine derivatives useful as calmodolin inhibitors

A compound represented by formula (I): wherein Q represents an aryl group, a heterocyclic group, a diarylmethyl group, an aralkyl group composed of an aryl group and an alkylene group, an alkyl group or a cycloalkyl group, in which the aryl group, heterocyclic group, and the aryl moiety of the diarylmethyl group and aralkyl group may be substituted with one or more substituents; R represents a bicyclic, substituted, nitrogen-containing heterocyclic group or a substituted phenyl group, in which the nitrogen-containing heterocyclic group is composed of a 5-membered, substituted, aromatic or saturated ring containing one or two nitrogen atoms and a 6-membered ring; and Z represents an alkylene group, an alkenylene group, an alkylene group, a carbonyl group, an alkylene group containing a carbonyl group or an oxalyl group,or a salt thereof. The compound has calmodulin inhibitory activity and is useful as a treating agent for diseases in the circulatory organs or in the cerebral region which are caused by excessive activation of calmodulin.